Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate vaginal inserts for cervical intraepithelial neoplasia (CIN2/3)
NCT04098744Phase 2Recruiting
- Sponsor
- Frantz Viral Therapeutics
- Start
- Sep 2020
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in cervical intraepithelial neoplasia (CIN), sponsored by Frantz Viral Therapeutics. Started Sep 2020; status: recruiting.
02
Drugs
artesunate
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT04098744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098744.